Odyssey Health (ODYY) Non-Current Debt (2020 - 2026)
Odyssey Health's (ODYY) quarterly Non-Current Debt came in at $25000.0 in Q2 2026, down 98.74% year-on-year from $2.0 million in Q2 2025, and down 99.54% quarter-over-quarter from $5.4 million in Q1 2026.
Odyssey Health (ODYY) Non-Current Debt (2020 - 2026) Analysis & Trends
Odyssey Health's Non-Current Debt history runs 7 years deep, the most recent figure standing at $25000.0 for Q2 2026.
- On a quarterly basis, Non-Current Debt fell 98.74% year-over-year to $25000.0 in Q2 2026; TTM through Apr 2026 was $25000.0, a 98.74% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, up 17.81% from the prior year.
- Non-Current Debt declined to $25000.0 in Q2 2026 per ODYY's latest filing, from $5.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $5.4 million in Q1 2026 and bottomed at $25000.0 in Q1 2022.
- The 5-year median for Non-Current Debt is $2.0 million (2024), against an average of $1.9 million.
- Across the five-year window, Non-Current Debt soared 9140.0% in 2023 and sank 98.74% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $1.7 million in 2022, then jumped by 46.52% to $2.5 million in 2023, then fell by 21.48% to $2.0 million in 2024, then rose by 8.87% to $2.2 million in 2025, then tumbled by 98.84% to $25000.0 in 2026.
- Per Business Quant, the three latest ODYY Non-Current Debt figures stand at $25000.0 (Q2 2026), $5.4 million (Q1 2026), and $2.2 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 25,000.00 |
| Jan 31, 2026 | 5.39 Mn |
| Oct 31, 2025 | 2.16 Mn |
| Jul 31, 2025 | 1.98 Mn |
| Apr 30, 2025 | 1.98 Mn |
| Jan 31, 2025 | 1.98 Mn |
| Oct 31, 2024 | 1.98 Mn |
| Jul 31, 2024 | 1.68 Mn |
| Apr 30, 2024 | 1.68 Mn |
| Jan 31, 2024 | 1.63 Mn |
| Oct 31, 2023 | 2.53 Mn |
| Jul 31, 2023 | 2.43 Mn |
| Apr 30, 2023 | 2.23 Mn |
| Jan 31, 2023 | 2.31 Mn |
| Oct 31, 2022 | 1.73 Mn |
| Jul 31, 2022 | 1.58 Mn |
| Apr 30, 2022 | 25,000.00 |
| Jan 31, 2022 | 25,000.00 |
| Jul 31, 2021 | 1.09 Mn |
| Jan 31, 2021 | 50,000.00 |